| P50 | author | Ray Peebles | Q86177149 |
| P2093 | author name string | Timothy S Blackwell | |
| | Vasiliy V Polosukhin | |
| | D-S Cheng | |
| | James R Sheller | |
| | Daphne Mitchell | |
| P2860 | cites work | Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site | Q28142986 |
| | Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation | Q28395688 |
| | NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness | Q33695239 |
| | CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation | Q34067800 |
| | Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients | Q34195964 |
| | A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat. | Q35043860 |
| | Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells. | Q35048843 |
| | A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity | Q35048852 |
| | Signal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice | Q35855209 |
| | Innate immune activation in neutrophilic asthma and bronchiectasis. | Q36225599 |
| | Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation | Q36401739 |
| | Activation of transcription factor IL-6 (NF-IL-6) and nuclear factor-kappaB (NF-kappaB) by lipid ozonation products is crucial to interleukin-8 gene expression in human airway epithelial cells | Q40157918 |
| | CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation | Q40707024 |
| | Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation | Q40744186 |
| | Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus | Q40976499 |
| | Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology | Q41038908 |
| | Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness | Q41923388 |
| | Expression of the Potent Inflammatory Cytokines, GM-CSF, IL6, and IL8, in Bronchial Epithelial Cells of Asthmatic Patients | Q42081697 |
| | A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model | Q44187685 |
| | Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma | Q44534195 |
| | Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics | Q44863693 |
| | Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model | Q44945661 |
| | Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma | Q46588782 |
| | Decrease of interleukin-10-producing T cells in the peripheral blood of severe unstable atopic asthmatics | Q47323131 |
| | Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo | Q47810986 |
| | A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. | Q51669271 |
| | Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. | Q53555761 |
| | Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. | Q53574082 |
| | Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. | Q54518293 |
| | Effect of ozone on bronchial reactivity in atopic and nonatopic subjects | Q54565436 |
| | Importance of airway inflammation for hyperresponsiveness induced by ozone | Q71757506 |
| | Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma | Q73163202 |
| | Rapid up-regulation of CXC chemokines in the airways after Ag-specific CD4+ T cell activation | Q73365855 |
| | Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids | Q73730745 |
| | Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice | Q74139304 |
| | Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen | Q74286698 |
| | Low-dose airborne endotoxin exposure enhances bronchial responsiveness to inhaled allergen in atopic asthmatics | Q79347659 |
| | Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice | Q80974292 |
| | Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo | Q81092757 |
| | Effects of allergen challenge on airway epithelial cell gene expression | Q81196627 |
| | CXC chemokines modulate IgE secretion and pulmonary inflammation in a model of allergic asthma | Q81485029 |
| P433 | issue | 10 | |
| P304 | page(s) | 883-895 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Experimental Lung Research | Q5421113 |
| P1476 | title | Nuclear factor kappa B induction in airway epithelium increases lung inflammation in allergen-challenged mice | |
| P478 | volume | 35 | |